to confirm the reported lack of major gastrointestinal side effects of naproxen , we gave 58 patients with active rheumatoid arthritis and significant gastrointestinal disease therapeutic doses of naproxen while closely monitoring them for signs and symptoms of gastrointestinal dysfunction .
C0027396
naproxen
C0003873
rheumatoid arthritis